Effect of extended adjuvant endocrine therapy with letrozole (L) in postmenopausal women with hormone-receptor (+) breast cancer after prior adjuvant therapy with an aromatase inhibitor (AI): NRG Oncology/NSABP B-42
| Autor: | E. Mamounas, H. Bandos, B. Lembersky, C. Geyer, L. Fehrenbacher, M. Graham, S. Paik, S. Swain, L. Wickerham, N. Wolmark |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
Oncology medicine.medical_specialty Postmenopausal women Aromatase inhibitor business.industry medicine.drug_class medicine.medical_treatment Letrozole Endocrine therapy General Medicine medicine.disease 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Breast cancer Hormone receptor 030220 oncology & carcinogenesis Internal medicine medicine Adjuvant therapy Surgery business Adjuvant medicine.drug |
| Zdroj: | The Breast. 32:S25-S26 |
| ISSN: | 0960-9776 |
| DOI: | 10.1016/s0960-9776(17)30112-1 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect